Evaluation of Sodium Relaxation Times and Concentrations in the Achilles Tendon Using MRI

Sodium magnetic resonance imaging (MRI) can be used to evaluate the change in the proteoglycan content in Achilles tendons (ATs) of patients with different AT pathologies by measuring the ²³Na signal-to-noise ratio (SNR). As ²³Na SNR alone is difficult to compare between different studies, because of the high influence of hardware configurations and sequence settings on the SNR, we further set out to measure the apparent tissue sodium content (aTSC) in the AT as a better comparable parameter. Ten healthy controls and one patient with tendinopathy in the AT were examined using a clinical 3 Tesla (T) MRI scanner in conjunction with a dual tuned ¹H/²³Na surface coil to measure ²³Na SNR and aTSC in their ATs. ²³Na T₁ and T₂* of the AT were also measured for three controls to correct for different relaxation behavior. The results were as follows: ²³Na SNR = 11.7 ± 2.2, aTSC = 82.2 ± 13.9 mM, ²³Na T₁ = 20.4 ± 2.4 ms, ²³Na T_2s* = 1.4 ± 0.4 ms, and ²³Na T_2l* = 13.9 ± 0.8 ms for the whole AT of healthy controls with significant regional differences. These are the first reported aTSCs and ²³Na relaxation times for the AT using sodium MRI and may serve for future comparability in different studies regarding examinations of diseased ATs with sodium MRI.